Synthetic Biologics

+$0.0053 (+2.21%) Today
+$0.0135 (+5.51%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SYN and other ETFs, options, and stocks.

About SYN

Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004.

CEO
Steven A. Shallcross
Employees
10
Headquarters
Rockville, Maryland
Founded
2001

SYN Key Statistics

Market cap
32.35M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.40M
High today
$0.2599
Low today
$0.2352
Open price
$0.236
Volume
1.83M
52 Week high
$1.22
52 Week low
$0.215

SYN Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure